英文摘要 |
Objective: Gout and hyperuricemia are associated with damage to multiple organs, metabolic syndrome, cardiovascular disease, and chronic kidney disease. Current evidence is insufficient for developing recommendations regarding early diagnosis of gout and treatment in asymptomatic hyperuricemia (AH) patients. Musculoskeletal ultrasound can detect tophi deposition, cartilage abnormalities, joint effusion, and bony erosions and thus enable early diagnosis of gout. We investigated the effectiveness of ultrasound in early diagnosis of gout in patients with AH. Methods: In this cross-sectional, controlled study, ultrasound was used to examine six joints, i.e., the bilateral first metatarsophalangeal joints, ankles, and knees. Two characteristic ultrasound findings for gout—the double contour (DC) sign and tophi—and selected risk factors were evaluated. Differences were compared with the chi-square test or unpaired t test. Results: We enrolled 51 patients with hyperuricemia—30 with AH and 21 with gout—and 10 normouricemic controls. DC signs were seen in 90% of AH patients and 76.2% of gout patients. Tophi were seen in 26.7% of AH patients and 33.3% of gout patients. No such findings were present in controls. Conclusion: The prevalence of DC sign was high in AH patients. The presence of the DC sign on ultrasound had a good diagnostic value (high sensitivity and high specificity) for AH patients. |